Posted on September 4th, 2010 by Health News
ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, announced the launch of its Dip and Read™ Protein G biosensor for rapid detection and quantification of numerous types of mammalian immunoglobulin (IgG), an antibody molecule, from solution…
No Comments »
Filed under: Pharmacy News
Posted on August 25th, 2010 by Health News
Perrigo Company announced it received FDA clearance on August 23, 2010 to manufacture infant formula liquid concentrate and ready-to-use products through its partner Kerry Proteins and Nutritionals located in Sainte Claire, Quebec.
No Comments »
Filed under: Pharmacy News
Posted on August 24th, 2010 by Health News
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that it has received regulatory clearance from the U.S. Food and Drug Administration (FDA) to conduct a Phase II clinical trial in the U.S. of its longer-acting version of human growth hormone, hGH-CTP.
No Comments »
Filed under: Pharmacy News
Posted on August 24th, 2010 by Health News
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,759,304, entitled “Targeting Complement Factor H For Treatment of Diseases”, covering the composition of matter for its lead product candidate, TT30, a novel [...]
No Comments »
Filed under: Pharmacy News
Posted on August 24th, 2010 by Health News
After decades of dreaming the drug developer’s impossible dream, scientists finally are reporting progress in making drugs that target the “untouchables” among the body’s key players in health and disease. They are the hundreds of thousands of proteins that many scientists considered to be “undruggable,” meaning that previous efforts to develop a drug against them [...]
No Comments »
Filed under: Pharmacy News
Posted on August 20th, 2010 by Health News
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the United States Food and Drug Administration (FDA) granted orphan designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in [...]
No Comments »
Filed under: Pharmacy News
Posted on August 20th, 2010 by Health News
Mirus Bio now offers a new transfection kit ideal for biotherapeutic protein production in large pharma and biotech settings. Mirus Bio’s new TransIT-PRO™ Kit will decrease time to produce usable protein by maximizing target protein yields through transient transfection…
No Comments »
Filed under: Pharmacy News
Posted on August 17th, 2010 by Health News
American women who ate more protein-rich foods instead of red meat had a significantly lower risk of developing heart disease, according to a study reported in Circulation: Journal of the American Heart Association. Eating more fresh red meat, processed red meat and high-fat dairy carried an increased risk of heart disease in [...]
No Comments »
Filed under: Women's Health
Posted on August 12th, 2010 by Health News
BioMimetic Therapeutics, Inc. today announced that it has received orphan drug designation from the Food and Drug Administration for its protein therapeutic, recombinant human platelet derived growth factor, to be used in conjunction with autograft and/or commercially available osteochondral allograft for the treatment of osteochondritis dissecans of the knee, elbow or ankle.
No Comments »
Filed under: Pharmacy News
Posted on August 12th, 2010 by Health News
Amorfix Life Sciences, a product development company focused on misfolded protein diseases, today announced its operational and financial results for the three months ended June 30, 2010.
No Comments »
Filed under: Pharmacy News
